An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604

NCT06157255 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AZD4604 Inhalation Powder, 1 mg
DRUG: [14C]AZD4604 Solution for Infusion 6 μg/mL (NMT 37.0 kBq/5 mL)
DRUG: [14C]AZD4604 Oral Solution, 4 mg (NMT 37.0 kBq)

Sponsor

AstraZeneca

Collaborators

[object Object]